Black Bird Biotech Launches MiteXstream(TM) Online Store for Direct Sales to Commercial and Home Users
Back to Newsroom
Mentioned in this Article

Black Bird Biotech Launches MiteXstream(TM) Online Store for Direct Sales to Commercial and Home Users

Thursday, October 7, 2021 8:30 AM
Share this article now
Topic:
Company Update
Black Bird Biotech, Inc.

FLOWER MOUND, TX / ACCESSWIRE / October 7, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, announced today that it has launched an online store for its game-changing biopesticide, MiteXstreamTM, to facilitate direct sales to commercial and home users. The new www.mitexstream.com website has been redesigned to better handle traffic driven to it by BBBT's marketing efforts within the dynamic cannabis industry, one that is expected to grow to $45 billion by 2025 [Source: Brightfield Group]. BBBT also is focusing marketing efforts on potential large customers across the agricultural spectrum, including, in addition to large cannabis grows, coffee farms ($20 billion in global sales annually), vineyards ($4.5 billion in U.S. sales annually) and plant and flower farms ($16 billion in U.S. sales annually).

"We are excited to launch our MiteXstream online store to sell directly to commercial and home users, especially to growers and home gardeners, who battle mites of all types, as well as molds and mildews, like powdery mildew, on a daily basis" said Fabian Deneault, President of BBBT. "We have also included a MiteXstream 101 link that provides a clear explanation of MiteXstream, as we see it."

MiteXstreamTM is available for sale to customers located in Colorado, Oregon, Wyoming, Nevada, Montana, Oklahoma, Massachusetts, Kentucky and Delaware, with pending applications in all remaining states, except California, the application for which is nearing completion.

For news and updates, shareholders, prospective investors and prospective business partners are encouraged to follow @BBBT_Corporate on Twitter ( https://twitter.com/BBBT_Corporate ). Also visit BBBT's corporate website, https://blackbirdbiotech.com, for additional information about the company.

About BBBT

Black Bird Biotech is positioned to exploit market segments with powerful, re-imagined biotech products. Its EPA-registered biopesticide, MiteXstreamTM, eradicates mites and similar pests, including spider mites (a lethal pest in cannabis, grapes, hops, coffee, strawberries and many other agricultural crops), and eliminates molds and mildews. MiteXstreamTM is a pesticide, but it is not a poison - it's a pesticide re-imagined. The MiteXstreamTM Edge: use through the day of harvest without concern for residual "pesticide" violations, including in state cannabis testing. MiteXstreamTM is the foundational element of the company that carries vast potential worldwide as a highly effective, safe and extremely cost-effective replacement for many traditional "poisonous" pesticides.

Forward Looking Statements:

This current press release contains "forward-looking statements," as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future, including but not limited to, any products sold or cash flow from operations.

Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with distribution and difficulties associated with obtaining financing on acceptable terms. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that the beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to our most recent annual report for our last fiscal year, our quarterly reports, and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

Contact:

Eric Newlan
Vice President
833-223-4204
[email protected]
www.blackbirdbiotech.com

SOURCE: Black Bird Biotech, Inc.

Back to Newsroom
Copyright 2021 © ACCESSWIRE. All rights reserved. Privacy Policy  |   Terms and Conditions